Risk of Fatal Kidney Condition Results in New Warnings for Gadolinium-Based Contrasts Used in MRI and MRA Procedures

Gadolinium-based contrast agents (GBCAs) are intravenous drugs used in diagnostic imaging procedures to enhance the quality of magnetic resonance imaging (MRI) or magnetic resonance angiography (MRA). Earlier this year, the FDA announced it was requiring that GBCA's carry new warnings about the risk of nephrogenic systemic fibrosis (NSF) when these drugs are administered to certain… Learn More »